You are here

Home » About the TGA » TGA Internet site archive » Archived presentations » Archived presentations 2017
TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

TGA presentation: Industry, Sydney, 25 May 2017

New e-form for minor variations

5 June 2017

On this page: Disclaimer | Presentation | Transcript | Print version

Disclaimer

These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.

The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.

Presentation

  • Presented by: Felicity Jameson, Jola Samoc
  • Presented at: Industry presentation, Sydney
  • Presentation date: 25 May 2017
  • Presentation summary: To provide prescription medicines regulatory affairs personnel with information on development of the new minor variations e-form.

Transcript

Show transcript for this slideshow

New e-form for minor variations

Felicity Jameson, Klara Koelmeyer, Jola Samoc
Medicines Regulation Division, Therapeutic Goods Administration

: Industry presentation, Sydney, 25 May 2017

Slide 1 - Minor variations to prescription medicines

  • New electronic form
  • How will it help you apply for minor variations
  • Next steps

Slide 2 - Reforms context

Reducing regulatory burden

  • Need for improvements to processes
  • Acknowledged in the Review of Medicines and Medical Devices (MMDR) -
  • Staged implementation

Slide 3 - New electronic form

First step for prescription medicines

  • One-stop shop: Consolidating six paper forms into one electronic portal
  • Reduced time and effort in making minor variations applications
  • More efficient processing of requests

Slide 4 - Benefit

Easy to identify your ARTG entries

screenshot1ADD IMAGE

Slide 5 - Benefit

Easy selection of types of minor variations

screenshot2ADD IMAGE

Slide 6 - Benefit

Summary of changes and associated fees before you submit

screenshot3ADD IMAGE

Slide 7 - Benefit

Submission number generated at point of submission

screenshot4ADD IMAGE

Slide 8 - Next steps

  • e-form testing
    • External stakeholders involved
  • e-form launch
    • After successful testing
  • Guidance updated and published
    • Printable version and e-book
  • Ongoing improvements
    • New 'notifications' process - pending new legislation

Slide 9 - More information

Prescription medicines reforms

https://www.tga.gov.au/prescription-medicine-regulatory-reforms

Print version

How to access a pdf document